Upcoming webinars
AMCP PIE Webinar
An Investigational RNA-Targeted Long-Term Prophylactic Medicine for Hereditary Angioedema (HAE)b
Date: Tuesday, May 13, 2025
Time: 2:00-3:00 pm ET
This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.
This PIE webinar is sponsored by Ionis Pharmaceuticals, Inc. The content of the webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP or FormularyDecisions. FormularyDecisions is proud to partner with AMCP to enable information sharing between healthcare decision-makers and biopharma companies.
Time: 2:00-3:00 pm ET
This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.
This PIE webinar is sponsored by Ionis Pharmaceuticals, Inc. The content of the webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP or FormularyDecisions. FormularyDecisions is proud to partner with AMCP to enable information sharing between healthcare decision-makers and biopharma companies.
AMCP PIE Webinar
Pediatric Myopia Progression in the US: Addressing the Disease and Unmet Need Behind an Emerging Epidemicb
Date: Wednesday, May 21, 2025
Time: 2:00-3:00 pm ET
This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.
This PIE webinar is sponsored by Sydnexis. The content of the webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP or FormularyDecisions. FormularyDecisions is proud to partner with AMCP to enable information sharing between healthcare decision-makers and biopharma companies.
Time: 2:00-3:00 pm ET
This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.
This PIE webinar is sponsored by Sydnexis. The content of the webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP or FormularyDecisions. FormularyDecisions is proud to partner with AMCP to enable information sharing between healthcare decision-makers and biopharma companies.
Webinar archive
Past Webinar Topics
- AMCP PIE Webinar: UGN-102 Pre-Approval Information Exchange (PIE) Presentationa
Conducted on: March 26, 2025 - Cencora | NASP Webinar: Enhancing Specialty Drug Review and Formulary Insights
Conducted on: March 25, 2025 - AMCP PIE Webinar: Investigational Cell-Based Autologous Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)a
Conducted on: March 4, 2025 - AMCP PIE Webinar: Overview of clinical data for a potential treatment for PTSD in adults
Conducted on: December 5, 2024 - AMCP PIE Webianr: Delgocitinib for the treatment of Chronic Hand Eczema (CHE)
Conducted on: November 20, 2024 - AMCP PIE Webinar: Vutrisiran Preapproval Information Exchange Webinar
Conducted on: October 30, 2024
PIE webinars are sponsored. The content of the webinars and opinions expressed by the presenters and those of the sponsor or presenters and not of AMCP or FormularyDecisions. FormularyDecisions is proud to partner with AMCP to enable information sharing between healthcare decision-makers and biopharma companies. At the time of the webinar, the product was in the clinical evaluation stage and had not been approved for use by the FDA. The safety and efficacy had not been established.